Vinflunine Plus Trastuzumab in Human Epidermal Growth Factor Receptor 2 (HER2neu) Over-Expressing Metastatic Breast Cancer
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This research study involves the anti-cancer medication trastuzumab and the investigational
drug vinflunine. The purpose of this trials is to see if trastuzumab and vinflunine used in
combination or vinflunine alone is effective in the treatment of metastatic breast cancer